Literature DB >> 221538

Transport of very low density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia.

S M Grundy, H Y Mok, L Zech, D Steinberg, M Berman.   

Abstract

Measurements of transport of triglycerides (TG) in very low density lipoproteins (VLDL) were carried out in 59 patients by injection of radioactive glycerol, determinations of specific activities of VLDL-TG for 48 h thereafter, and treatment of the data by multicompartmental analysis. The patients were divided into three groups: normal weight (89-120% ideal weight), mildly obese (120-135% ideal weight), and markedly obese (135% ideal weight). They had varying levels of VLDL-TG ranging from normal to markedly elevated. In many subjects, there was a positive correlation between concentrations and transport of VLDL indicating that overproduction of VLDL-TG contributed to hypertriglyceridemia. In others, and particularly in several markedly obese subjects, transport rates were greatly increased without significant hypertriglyceridemia, suggesting that they had enhanced capacity to clear TG. In all groups, however, there were patients whose degree of hypertriglyceridemia seemed out of proportion to their transport rates. This finding and the fact that many patients have increased secretion of VLDL-TG without elevated plasma TG suggests that both overproduction of VLDL-TG and insufficient enhancement of clearance contributed to the development of hypertriglyceridemia.The data showed a poor correlation between transport rates determined by our multicompartment analysis and single-exponential analysis used previously by other investigators (r = 0.46); this comparison was not improved by segregating patients according to their degree of obesity. Although two conversion pathways (fast and slow synthetic paths) were required to fit the data, there was no correlation between transport rates and the ratio of the two pathways. Also, despite the known pathway of conversion of VLDL to low density lipoprotein, no correlation was found between VLDL-TG transport rates and estimated low density lipoprotein-cholesterol concentrations.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221538      PMCID: PMC372076          DOI: 10.1172/JCI109422

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man.

Authors:  J W Farquhar; A Frank; R C Gross; G M Reaven
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

Review 2.  Carbohydrate intolerance and lipemia.

Authors:  E L Bierman; D Porte
Journal:  Ann Intern Med       Date:  1968-04       Impact factor: 25.391

3.  The rate of appearance of FFA in plasma triglyceride of normal and obese subjects.

Authors:  H I Miller; W M Bortz; B C Durham
Journal:  Metabolism       Date:  1968-06       Impact factor: 8.694

4.  Interactions of obesity, and glucose and insulin levels in hypertriglyceridemia.

Authors:  S Ford; R C Bozian; H C Knowles
Journal:  Am J Clin Nutr       Date:  1968-09       Impact factor: 7.045

5.  Plasma free fatty acid and triglyceride turnover in obesity.

Authors:  P J Nestel; H M Whyte
Journal:  Metabolism       Date:  1968-12       Impact factor: 8.694

6.  Dynamics of plasma triglyceride turnover in man.

Authors:  W G Ryan; T B Schwartz
Journal:  Metabolism       Date:  1965-12       Impact factor: 8.694

7.  Kinetics of triglyceride turnover of very low density lipoproteins of human plasma.

Authors:  G M Reaven; D B Hill; R C Gross; J W Farquhar
Journal:  J Clin Invest       Date:  1965-11       Impact factor: 14.808

8.  Triglyceride turnover in coronary heart disease and the effect of dietary carbohydrate.

Authors:  P J Nestel
Journal:  Clin Sci       Date:  1966-08       Impact factor: 6.124

9.  Role of insulin in endogenous hypertriglyceridemia.

Authors:  G M Reaven; R L Lerner; M P Stern; J W Farquhar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

10.  [Turnover rate of free fatty acids and triglycerides in blood in essential hyperlipemia].

Authors:  S Sailer; F Sandhofer; H Braunsteiner
Journal:  Klin Wochenschr       Date:  1966-09-01
View more
  40 in total

1.  Relationship between lifestyle and serum lipid and lipoprotein levels in middle-aged Japanese men.

Authors:  N Nakanishi; K Nakamura; S Ichikawa; K Suzuki; K Tatara
Journal:  Eur J Epidemiol       Date:  1999-04       Impact factor: 8.082

2.  Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

Authors:  H N Ginsberg; N A Le; I J Goldberg; J C Gibson; A Rubinstein; P Wang-Iverson; R Norum; W V Brown
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

3.  Evaluation of CETP activity in vivo under non-steady-state conditions: influence of anacetrapib on HDL-TG flux.

Authors:  David G McLaren; Stephen F Previs; Robert D Phair; Steven J Stout; Dan Xie; Ying Chen; Gino M Salituro; Suoyu S Xu; Jose M Castro-Perez; Gregory J Opiteck; Karen O Akinsanya; Michele A Cleary; Hayes M Dansky; Douglas G Johns; Thomas P Roddy
Journal:  J Lipid Res       Date:  2015-12-09       Impact factor: 5.922

4.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

5.  [Incorporation of 15N in VLDL and LDL: in vivo synthesis of apolipoprotein B in the post-absorptive and fasting state].

Authors:  P Schauder; J Arends; G Schäfer; K Langer; D M Bier
Journal:  Klin Wochenschr       Date:  1989-03-01

6.  Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.

Authors:  Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; Suryaprakash Raichur; Ravi K Damarla; Cynthia Gershome; Juluri Suresh; Ramanujam Rajagopalan
Journal:  Br J Pharmacol       Date:  2003-09-01       Impact factor: 8.739

7.  Effect of somatostatin-induced suppression of postprandial insulin response upon the hypertriglyceridemia associated with a high carbohydrate diet.

Authors:  H N Ginsberg; A Jacobs; N A Le; J Sandler
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Abnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatment.

Authors:  S Eisenberg; D Gavish; Y Oschry; M Fainaru; R J Deckelbaum
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged.

Authors:  A Aarsland; D Chinkes; R R Wolfe; R E Barrow; S O Nelson; E Pierre; D N Herndon
Journal:  Ann Surg       Date:  1996-06       Impact factor: 12.969

10.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III.

Authors:  C S Wang; W J McConathy; H U Kloer; P Alaupovic
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.